Trial Profile

No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin detemir (Primary) ; Insulin glargine; Insulin suspension isophane
Indications Diabetes mellitus
Focus Pharmacodynamics

07 Nov 2012 Planned number of patients changed from 10 to 12 as reported by European Clinical Trials Database.
01 Jul 2010 Actual volunteer numbers reported as 10
11 Dec 2007 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com